Annual Accounts Receivable
N/A
December 31, 2023
Summary
- FDMT annual accounts receivable is not available.
Performance
FDMT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- FDMT quarterly accounts receivable is not available.
Performance
FDMT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
FDMT Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
FDMT Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
4D Molecular Therapeutics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $0.00(0.0%) |
Jun 2022 | - | $0.00(0.0%) |
Mar 2022 | - | $0.00(-100.0%) |
Dec 2021 | $47.00 K | $47.00 K(-94.1%) |
Sep 2021 | - | $791.00 K(-35.1%) |
Jun 2021 | - | $1.22 M(+26.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $965.00 K(-35.1%) |
Dec 2020 | $1.49 M(+51.9%) | $1.49 M(+65.8%) |
Sep 2020 | - | $896.00 K(-8.4%) |
Dec 2019 | $978.00 K(-13.0%) | $978.00 K(-15.8%) |
Jun 2019 | - | $1.16 M(+3.3%) |
Dec 2018 | $1.12 M(+250.2%) | $1.12 M |
Dec 2017 | $321.00 K | - |
FAQ
- What is the all time high annual accounts receivable for 4D Molecular Therapeutics?
- What is the all time high quarterly accounts receivable for 4D Molecular Therapeutics?
What is the all time high annual accounts receivable for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual accounts receivable is $1.49 M
What is the all time high quarterly accounts receivable for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly accounts receivable is $1.49 M